SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-000902
Filing Date
2020-01-13
Accepted
2020-01-13 08:15:57
Documents
17
Period of Report
2020-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20200113.htm   iXBRL 8-K 42152
2 EX-99.1 rare-ex991_71.htm EX-99.1 32527
3 EX-99.2 rare-ex992_70.htm EX-99.2 75861
4 GRAPHIC ggflta23t3v2000001.jpg GRAPHIC 348834
5 GRAPHIC ghrvrbha3mea000001.jpg GRAPHIC 348834
6 GRAPHIC ghrvrbha3mea000002.jpg GRAPHIC 734523
  Complete submission text file 0001564590-20-000902.txt   2238664

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rare-20200113.xsd EX-101.SCH 5976
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20200113_lab.xml EX-101.LAB 18721
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20200113_pre.xml EX-101.PRE 11179
10 EXTRACTED XBRL INSTANCE DOCUMENT rare-8k_20200113_htm.xml XML 3414
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 20522878
SIC: 2834 Pharmaceutical Preparations